| CPS | combined positive score |
| CTLA-4 | cytotoxic T-lymphocyte antigen 4 |
| EBNA1 | Epstein–Barr nuclear antigen 1 |
| EBV | Epstein–Barr virus |
| EBV-GC | Epstein–Barr virus—gastric cancer |
| ECOG | Eastern Cooperative Oncology Group |
| GC | gastric cancer |
| HBV | hepatitis B virus |
| HCC | hepatocellular carcinoma |
| HCV | hepatitis C virus |
| HHV-8 | human gammaherpesvirus 8 |
| HIV | human immunodeficiency viruses |
| HPV | human papillomavirus |
| HTLV-1 | human T-lymphotropic virus 1 |
| ICIs | immune checkpoint inhibitors |
| LMP1 | latent membrane protein 1 |
| LMP2 | latent membrane protein 2 |
| NPC | nasopharyngeal carcinoma |
| MCPyV | Merkel cell polyomavirus |
| ORR | overall response rate |
| OS | overall survival |
| PD-1 | programmed death 1 |
| PDL-1 | programmed death-ligand 1 |
| PFS | progression free survival |
| R/M | recurrent/metastatic |
| TILs | tumour-infiltrating lymphocytes |